Park Ha Biological Technology (BYAH) Receivables (2023 - 2026)

Park Ha Biological Technology has reported Receivables for 4 years, with the latest figure at -$3.5 million in Q2 2026.

• On a quarterly basis, Receivables fell 436.28% year-over-year to -$3.5 million in Q2 2026; TTM through Apr 2026 was -$3.5 million, a 436.28% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, up 8.92% from the prior year.
• Receivables was -$3.5 million for Q2 2026 at Park Ha Biological Technology, down from $255879.0 in the prior quarter.
• The five-year high for Receivables was $1.0 million in Q2 2025, with the low at -$3.5 million in Q2 2026.
• Average Receivables over 4 years is -$261300.4, with a median of $255879.0 recorded in 2025.
• The sharpest annual moves came in 2024 and 2026: Receivables soared 749.6% in 2024, then plunged 436.28% in 2026.
• Over 4 years, Receivables stood at $95980.0 in 2023, then jumped by 749.6% to $815446.0 in 2024, then plunged by 68.62% to $255879.0 in 2025, then plunged by 1475.96% to -$3.5 million in 2026.
• The last three Receivables figures came in at -$3.5 million (Q2 2026), $255879.0 (Q4 2025), and $1.0 million (Q2 2025), per Business Quant data.